Abstract: A method for treating preselected diseases comprising the steps of providing a therapeutic dose of a mesenchymal stem cell composition, the mesenchymal stem cell composition comprising mesenchymal stem cells harvested from at least one tissue selected from the group consisting of placental tissue, bone marrow, dental tissue, testicle tissue, and dermal tissue; and systemically administering the mesenchymal stem cell composition to the patient suffering from a preselected disease or diseased state through an intravenous injection.
Type:
Application
Filed:
August 31, 2011
Publication date:
March 1, 2012
Applicant:
Renovocyte, LLC
Inventors:
Erik John Woods, Shelly J. Zacharias, Sreedhar Thirumala